Skip to content

Idexx Laboratories IDXX Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin247.1%+3.7pp246.3%+4.0pp245.6%+4.5pp244.6%+4.3pp243.4%+3.6pp
Operating margin125.7%+10.0pp123.2%+6.7pp120.5%+3.1pp118.1%-0.5pp115.6%-4.2pp
Net margin98.3%+7.9pp96.4%+5.5pp94.6%+3.4pp92.5%+0.9pp90.4%-1.4pp
EBITDA margin139.1%+10.3pp136.7%+7.4pp134%+3.8pp131.5%+0.3pp128.9%-3.6pp
Free cash flow margin91.5%+6.4pp88.7%+3.8pp84.8%-0.4pp82.3%-1.3pp85.1%+6.8pp
Returns
Return on equity268.6%+29.0pp255%+2.8pp246.5%-28.8pp241.3%-67.4pp239.7%-108pp
Return on assets124.8%+16.6pp118.9%+9.8pp114.1%+4.0pp110.5%-1.4pp108.2%-5.7pp
Return on invested capital213.5%+31.8pp202%+16.6pp194.7%+1.6pp187.9%-15.4pp181.7%-30.5pp
Efficiency
Asset turnover5.1×+0.3×4.9×+0.1×4.8×0.0×4.8×-0.1×4.8×-0.2×
Inventory turnover16.8×+1.2×16.3×+0.8×16×+0.5×15.7×+0.3×15.6×+0.1×
Liquidity
Current ratio4.6×-0.6×4.7×-1.0×4.8×-1.2×-0.9×5.3×-0.6×
Quick ratio3.4×-0.4×3.4×-0.8×3.4×-1.0×3.6×-0.8×3.8×-0.4×
Cash ratio0.6×-0.5×0.6×-0.7×0.7×-0.8×0.9×-0.7×1.1×-0.3×
Leverage
Debt-to-equity1.6×-0.4×1.7×-0.2×1.8×-0.2×1.9×-0.4×-0.6×
Debt-to-assets0.7×-0.2×0.8×-0.1×0.8×-0.1×0.9×-0.1×0.9×-0.2×
Net debt / EBITDA1.2×-0.3×1.4×0.0×1.5×+0.1×1.5×+0.1×1.5×-0.3×
Interest coverage143×+4.2×143.9×+11.4×145.1×+22.3×143.6×+31.1×138.8×+36.5×
Per Share
Book value per share$76.59+1.8%$74.85-1.9%$74.20-0.8%$74.33+5.0%$75.27+16.1%
Valuation
Market capitalization$192.43B+28.2%$181.83B+13.0%$161.66B-6.7%$152.3B-9.2%$150.12B-11.2%
Enterprise value$194.14B+27.7%$183.75B+13.0%$163.63B-6.4%$154.25B-9.0%$152B-11.2%
Price / earnings184.8×+12.5×182.1×-3.9×169.2×-33.2×167.6×-30.8×172.2×-31.0×
Price / sales45.4×+6.5×44×+1.8×40.2×-6.0×38.8×-6.7×38.9×-7.7×
Price / book124.3×+28.2×119.1×+17.9×106.7×-4.4×99.8×-13.5×96.1×-29.7×
EV / EBITDA131.7×+9.4×129.8×-2.2×120.9×-22.2×119.4×-20.7×122.3×-20.3×
EV / sales45.8×+6.4×44.5×+1.8×40.7×-6.0×39.3×-6.7×39.4×-7.8×
Free cash flow yield8.1%-0.7pp8.2%0.0pp8.6%+1.2pp8.6%+1.2pp8.8%+2.1pp
Earnings yield8.7%-0.7pp8.9%+0.2pp9.6%+1.6pp9.6%+1.5pp9.4%+1.5pp
PEG ratio9.7×-25.5×19.5×-6.3×24.4×+3.9×30.9×+17.5×35.2×+26.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Idexx Laboratories's profit margins?
Idexx Laboratories (IDXX) runs a 62.1% gross margin and a 31.6% operating margin, with a 24.6% net margin.
Where do Idexx Laboratories's ratios come from?
Every ratio is computed from Idexx Laboratories's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.